Intranasal carbetocin formulations and the autistic method of treatment

Intranasal carbetocin formulations and the autistic method of treatment

  • CN 101,677,948 A
  • Filed: 09/28/2007
  • Published: 03/24/2010
  • Est. Priority Date: 06/07/2007
  • Status: Active Application
First Claim
Patent Images

1. pharmaceutical preparation that is used for the intranasal delivery carbetocin, it comprises carbetocin, solubilizing agent, chelating agen, tension regulator and two or more buffer agents.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×